ESC 365 - GALILEO: Rivaroxaban in TAVR patients.

ESC Premium Access

GALILEO: Rivaroxaban in TAVR patients.

Session: The future is in the pipeline

Topic: Miscellaneous

Speaker: Professor S. Windecker (Bern, CH)

Event: ESC CONGRESS 2016

Presentation

About the speaker

Professor Stephan Windecker

Bern University Hospital, Inselspital, Bern (Switzerland)

29 presentations

4 followers

3 more presentations in this session

Rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications.

Speaker: Professor M. Boehm (Homburg, DE)

Research Strategy: Searching for a cure for heart failure.

Speaker: Associate Professor R. Fritsche (Molndal, SE)

Novel drug-filled stent designed to achieve controlled and sustained drug elution without a polymer.

Speaker: Doctor G. Stone (New York, US)

Access the full session

The future is in the pipeline

Speakers: Professor S. Windecker, Professor M. Boehm, Associate Professor R. Fritsche, Doctor G. Stone

About the event

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

Congress

Related content

ESC Premium Access

Colchicine in Acute Myocardial Infarction

27 August 2021

ESC Premium Access

REDUCE-IT PRIOR MI: Reduction in Ischemic Events, Including Cardiovascular Mortality, with Icosapent Ethyl in Patients with Prior Myocardial Infarction

27 August 2021

ESC Premium Access

Ticagrelor implementation in PCI-treated ACS patients

27 August 2021

This platform is supported by